Vistagen Therapeutics (VTGN) Q1 2026 Earnings

Feb 12Confirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-0.54
-0.5
-0.47
-0.43

Details

Expected EPS
-0.48688
Actual EPS
-0.45
Surprise EPS
0.04
Surprise Percent
+7.57%

Description

⁨Vistagen Therapeutics⁩ (⁦VTGN⁩) has reported earnings of ⁦-0.45⁩ per share for ⁦Q1 2026⁩.

0 Comments

Share your thoughts